Previously Recorded
WEBINAR M&A Dealmakers Roundtable: Insights on the Life Sciences M&A Market
Event summary
M&A deals in the life sciences industry have unique aspects that have been made more complex to navigate in today’s volatile environment. The seasoned dealmakers will discuss the steps and strategies for public and private life sciences companies to take early on to set themselves up for a successful exit down the road.
Topics include
- How a life sciences company is assessed from a buyer perspective
- Strategic timing of a potential sale
- Tactics for long-term preparation
Speakers
- Barbara Borden – M&A Co-chair, Cooley
- Andy Pasternak – Executive VP and Chief Strategy Officer, Horizon Therapeutics
- Eric Tokat – Partner, Centerview Partners
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.